BioLife Solutions, Inc. (BLFS)
37.22
+0.12
(+0.32%)
USD |
NASDAQ |
Aug 24, 16:00
37.22
0.00 (0.00%)
After-Hours: 20:00
BioLife Solutions Shareholders Equity (Quarterly) : 420.00M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 420.00M |
| March 31, 2026 | 372.23M |
| December 31, 2025 | 371.89M |
| September 30, 2025 | 353.74M |
| June 30, 2025 | 347.16M |
| March 31, 2025 | 352.62M |
| December 31, 2024 | 348.91M |
| September 30, 2024 | 325.46M |
| June 30, 2024 | 321.44M |
| March 31, 2024 | 333.40M |
| December 31, 2023 | 337.66M |
| September 30, 2023 | 332.02M |
| June 30, 2023 | 352.13M |
| March 31, 2023 | 358.11M |
| December 31, 2022 | 364.19M |
| September 30, 2022 | 408.25M |
| June 30, 2022 | 412.31M |
| March 31, 2022 | |
| December 31, 2021 | 478.05M |
| September 30, 2021 | 489.26M |
| June 30, 2021 | 452.28M |
| March 31, 2021 | 208.78M |
| December 31, 2020 | 205.25M |
| September 30, 2020 | 186.85M |
| June 30, 2020 | 105.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 67.71M |
| December 31, 2019 | 43.45M |
| September 30, 2019 | 76.96M |
| June 30, 2019 | 46.27M |
| March 31, 2019 | 44.37M |
| December 31, 2018 | 43.15M |
| September 30, 2018 | 43.93M |
| June 30, 2018 | 19.66M |
| March 31, 2018 | 10.47M |
| December 31, 2017 | 10.09M |
| September 30, 2017 | 7.214M |
| June 30, 2017 | 6.821M |
| March 31, 2017 | 2.804M |
| December 31, 2016 | 3.166M |
| September 30, 2016 | 6.162M |
| June 30, 2016 | 6.822M |
| March 31, 2016 | 7.443M |
| December 31, 2015 | 8.508M |
| September 30, 2015 | 9.152M |
| June 30, 2015 | 10.02M |
| March 31, 2015 | 10.84M |
| December 31, 2014 | 11.80M |
| September 30, 2014 | 12.67M |
| June 30, 2014 | 13.40M |
| March 31, 2014 | 14.08M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp. | 2.112B |
| Agilent Technologies, Inc. | 7.122B |
| Danaher Corp. | 52.58B |
| Thermo Fisher Scientific, Inc. | 52.68B |
| West Pharmaceutical Services, Inc. | 2.990B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 447.49M |
| Total Liabilities (Quarterly) | 27.49M |
| Debt to Equity Ratio | 0.0375 |
| Current Ratio | 9.694 |
| Net Debt Paydown Yield | 0.16% |